Unleashing unconventional antigens for cancer immunotherapy

Learn about our technology

The Enara Bio® purpose

Shining a light on Dark Antigen® and T-cell biology to enable people to live free from the shadow of cancer.

Our mission is to exploit previously uncharted genomic dark matter to develop cancer immunotherapies that deliver transformative benefit for broad patient populations.

To achieve our mission, we have built two innovative technology platforms:

EDAPT® pipeline that enables us to discover and validate a novel class of cancer-specific antigens derived from the genomic dark matter, which we call Dark Antigens®.

EnTiCE® platform for optimizing proprietary bispecific T-cell engagers to deliver best-in-class treatments for solid tumors.

We are rapidly advancing our lead program to the clinic, a bispecific T-cell engager that targets a previously undiscovered antigen that we have named DARKFOX™.

Read more about us

Who we are

We are a diverse, experienced, and rapidly growing team driven by a common purpose and united by our shared values. The culture we have developed enables each of us to make an impact and deliver on our vision.

Enara Bio Our Story Poster

Featured news